Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people joining as a "case" participant (those with a relevant health condition):
- People who are either a survivor of acute lymphoblastic leukemia (a type of blood cancer), or are currently living with a chronic lung disease related to being born premature, or have had a heart transplant
- People aged between 8 and 25 years old
- People who are at least 48 inches (4 feet) tall
- People who are able to walk around without any physical assistance
- People who speak English
- People whose blood pressure is within a normal range for their age (including those whose blood pressure is managed with medication)
- People whose blood oxygen level is above 92%
- People who are not pregnant
- For leukemia survivors specifically: people who finished their cancer treatment at least 3 months before entering the study
For people joining as a "control" participant (those without a relevant health condition):
- People aged between 8 and 25 years old
- People who are at least 48 inches (4 feet) tall
- People who are able to walk around without any physical assistance
- People who speak English
- People with no history of irregular heart rhythms or known heart problems
- People whose blood pressure is within a normal range for their age (including those whose blood pressure is managed with medication)
- People whose blood oxygen level is above 95%
- People who are not pregnant
Who may not be able to join:
For "case" participants:
- Leukemia survivors who received radiation to the head, or who had a bone marrow transplant
- People whose own doctor or the trial investigator considers them unsuitable for the study
For "control" participants:
- People with a history of cancer, chronic lung disease, heart transplant, or any other condition that may affect heart or lung function
- People whom the trial investigator considers unsuitable for the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pianosi Paolo, MD, Masonic Children's Hospital, University of Minnesota
Phone: 612-626-2140
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measure of Peak O2 intake during test exercise; Measure of Cardiac output during test exercise
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.